Related Experiment Video
Updated: Apr 25, 2026
Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
Published on: October 24, 2016
Small molecule inhibitors in veterinary oncology practice
1Veterinary Biosciences, The Ohio State University, 454 VMAB, 1925 Coffey Road, Columbus, OH 43210, USA.
Abstract:
Recent advances in molecular biology have permitted the identification and characterization of specific abnormalities regarding cell signaling and function in cancer cells. Proteins that are found to be dysregulated in cancer cells can serve as relevant targets for therapeutic intervention. Although there are several approaches to block proteins that contribute to cellular dysfunction, the one most commonly used involves a class of therapeutics called small molecule inhibitors. Such inhibitors work by disrupting critical pathways/processes in cancer cells, thereby preventing their ability to grow and survive.
Insights
Small molecule inhibitors target dysregulated proteins in cancer cells. These targeted therapies disrupt critical cellular pathways, hindering cancer growth and survival.
Area of Science:
- Molecular biology
- Cancer research
- Pharmacology
Background:
- Cancer cells exhibit specific molecular abnormalities affecting cell signaling and function.
- Dysregulated proteins in cancer are key targets for therapeutic strategies.
- Small molecule inhibitors are a common therapeutic approach to block protein function.
Purpose of the Study:
- To highlight the role of dysregulated proteins in cancer.
- To explain the mechanism of small molecule inhibitors in cancer therapy.
Main Methods:
- Identification and characterization of molecular abnormalities in cancer cells.
- Utilizing small molecule inhibitors to target dysregulated proteins.
Main Results:
- Small molecule inhibitors effectively disrupt critical cancer cell pathways.
- Targeted inhibition prevents cancer cell growth and survival.
Conclusions:
- Dysregulated proteins in cancer are viable therapeutic targets.
- Small molecule inhibitors represent a promising strategy for cancer treatment by disrupting essential cellular processes.
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...